Evidence map›Paper›PMID 41163977›Full record

ArticlePrecision radiation oncology2025

Preoperative multiparameter MRI-based prediction of Ki-67 expression in primary central nervous system lymphoma.

Jian Xu, Lili Zhang, Qingzeng Liu, Jian Zhu

Abstract read
In one paragraph

Article in Precision radiation oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Jian XuShandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan P. R. China.ORCID https://orcid.org/0009-0005-1220-6027
Lili ZhangLiaocheng People's Hospital of Shandong Province Liaocheng P. R. China.
Qingzeng LiuShandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan P. R. China.
Jian ZhuShandong Cancer Hospital and Institute Shandong First Medical University and Shandong Academy of Medical Sciences Jinan P. R. China.ORCID https://orcid.org/0000-0003-2257-4593

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Ki-67 is a key marker of tumor proliferation. This study aimed to develop machine learning models using single- and multi-parameter MRI radiomic features for the preoperative prediction of Ki-67 expression in primary central nervous system lymphoma (PCNSL), aiding prognosis and individualized treatment planning. Methods: A retrospective analysis of 74 patients was conducted using MRI scans, including T1, contrast-enhanced T1, T2, T2-FLAIR, DWI, and ADC sequences. Patients were categorized into high-expression (Ki-67 > 70%) and low-expression (Ki-67 ≤ 70%) groups. Tumor volumes of interest (VOIs) were manually delineated by radiologists, and 851 radiomic features were extracted using 3DSlicer. After preprocessing, including bias field correction and normalization, feature selection was performed using SelectKBest and ANOVA. Eight machine learning classifiers, including Logistic Regression, Random Forest, and SVM, were applied to single- and multi-parameter datasets. Results: Multiparameter models, particularly Naive Bayes and Logistic Regression, demonstrated superior predictive performance (AUC: 0.78, 0.73; AP: 0.90, 0.83) compared to single-parameter models. Decision curve analysis highlighted that Logistic Regression provides the highest net benefit, followed by Naive Bayes. Conclusion: Multiparameter MRI models are more accurate and stable for predicting Ki-67 expression in PCNSL, supporting clinical decision-making.

Indexed as

Ki‐67LymphomaMachine LearningMagnetic Resonance ImagingRadiomics

Identifiers

PMID41163977
PMCPMC12559913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.